BSc. Specialized Honours in Molecular Genetics | University of Guelph | Guelph
Doctor of Philosophy with Distinction in Molecular Genetics & Immunology | University of Guelph | Guelph
Postdoctoral Clinical Cytogenetics Fellowship | University of California | Los Angeles
Postdoctoral Clinical Cytogenetics Fellowship | Baylor College of Medicine | Houston
Dr. Mansoor is the President and CSO of The DNA Company, a leading and innovative provider of comprehensive Functional Genomics testing, consulting, and personalized health solutions.
Dr. Mansoor is widely regarded as a pioneer in medical genomics and has been the recipient of multiple academic and industry awards. He is the holder of several patents in the general fields of molecular diagnostics and genomics research and is one of the most sought-after national and international conference speakers in the genre of personalized medicine.
Prior to his role at The DNA Company, Dr. Mansoor was:
- Founder and President of ManaGene (2010-2018)
- CEO of Combimatrix (Nasdaq traded leader in diagnostic genomic microarrays) (2006-2010)
- Director of Genomics at Quest Diagnostics (The world’s largest reference laboratory with a market capitalization of over $10 billion US) (2003-2006)
- Director of Research and Development at Spectral Genomics (one of the industry’s first commercial genomic microarray developers spun out of Baylor College of Medicine under Dr. Mansoor’s scientific leadership)
Dr. Mansoor maintains an active clinical practice as a genomics consultant to some of the leading executive health clinics in Canada and abroad. Dr. Mohammed has served on the Canadian Board of Autistic Research and is a consultant to the world-renowned Toronto Center of Applied Genomics. He is also the Genomicist-in-Residence for the Autism Hope Alliance.
Dr. Mansoor is linked to the following digital media platforms:
Facebook: @thednacompany | Instagram: @thednaco | Twitter: @DrMansoorM